FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2911204 · Received January 11, 2013

Report

Report Number
2124215-2012-16545
Event Type
Injury
Date Received
January 11, 2013
Date of Event
November 23, 2012
Report Date
January 2, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE LEAD IS CURRENTLY UNDERGOING ANALYSIS. WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY THE RETURNED SEGMENT OF THE LEAD WAS THOROUGHLY INSPECTED AND ANALYZED. ONLY THE PROXIMAL SEGMENT OF THE LEAD WAS RETURNED WHICH HAD BEEN SEVERED 11 CENTIMETERS FROM THE IS-1 PIN. THE RETURNED SEGMENT OF THE LEAD WAS DETERMINED TO HAVE BEEN ELECTRICALLY CONTINUOUS. THE CLINICAL OBSERVATIONS WERE NOT ABLE TO BE CONFIRMED AS ONLY A SMALL PORTION OF THE LEAD WAS RETURNED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS RIGHT VENTRICULAR (RV) LEAD PRESENTED WITH NOISE, OVERSENSING AND INAPPROPRIATE SHOCK THERAPY. THE LEAD WAS REPORTED TO HAVE BEEN FRACTURED. PACING IMPEDANCES WERE GREATER THAN 2000 OHMS AND SHOCK IMPEDANCES WERE GREATER THAN 125 OHMS. THE PATIENT WAS SEEN FOR A LEAD REVISION PROCEDURE WHERE THE LEAD WAS ATTEMPTED TO BE EXPLANTED. DURING THE ATTEMPT, THE LEAD PULLED APART AND THE DISTAL END OF THE LEAD REMAINED IN THE PATIENT'S HEART. A NEW LEAD WAS THEN SUCCESSFULLY IMPLANTED. THE LEAD HAS BEEN RETURNED FOR ANALYSIS. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED..

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
18776 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0157

Patients

Seq Age Sex Outcome Treatment
1 74 YR Hospitalization| L| R A155| 0157| E110| 4472